713 Nanrilkefusp alfa, a high-affinity IL-15Rβγ agonist, promotes an innate and adaptive anti-tumour inflammatory environment as single agent or combined with anti-PD-1 in patients with advanced cancers

Títulos similares

• 713 Nanrilkefusp alfa, a high-affinity IL-15Rβγ agonist, promotes an innate and adaptive anti-tumour inflammatory environment as single agent or combined with anti-PD-1 in patients with advanced cancers
  por: Ulrich Moebius, et al.
  Publicado: (2023-11-01)
• 815 Combination with IL-15Rβγ superagonist, Nanrilkefusp alfa, enhances CAR T and BOXR T cell anti-tumor activity
  por: Irena Adkins, et al.
  Publicado: (2023-11-01)
• 1087 SOT201 is a novel cis-acting immunocytokine targeting IL-15Rβγ to reinvigorate PD-1+tumor infiltrating lymphocytes and potentiate anti-tumor efficacy
  por: Ulrich Moebius, et al.
  Publicado: (2023-11-01)
• IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment
  por: Mélanie Desbois, et al.
  Publicado: (2020-05-01)
• Impact of the IL-15 superagonist N-803 on lymphatic reservoirs of HIV
  por: Joshua Rhein, et al.
  Publicado: (2025-07-01)